Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Swedish Orphan Biovitrum AB (publ)
Long-Term Investments
Swedish Orphan Biovitrum AB (publ)
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Long-Term Investments
kr194m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
17%
|
|
Biogaia AB
STO:BIOG B
|
Long-Term Investments
kr28.1m
|
CAGR 3-Years
796%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
Hansa Biopharma AB
STO:HNSA
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bonesupport Holding AB
STO:BONEX
|
Long-Term Investments
kr1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vitrolife AB
STO:VITR
|
Long-Term Investments
kr56m
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
26%
|
|
BioArctic AB
STO:BIOA B
|
Long-Term Investments
kr1.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Long-Term Investments?
Long-Term Investments
194m
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Long-Term Investments amounts to 194m SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
17%
Over the last year, the Long-Term Investments growth was 44%. The average annual Long-Term Investments growth rates for Swedish Orphan Biovitrum AB (publ) have been 1% over the past three years , -4% over the past five years , and 17% over the past ten years .